Federated Hermes
CRBU icon

Federated Hermes’s Caribou Biosciences CRBU Stock Holding History

Federated Hermes’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Hold
2,722
– – ﹤0.01% 1925
2026
Q1 		$5.17K Hold
2,722
– – ﹤0.01% 1883
2025
Q4 		$4.33K Sell
2,722
-344
-11% -$722 ﹤0.01% 1904
2025
Q3 		$7.14K Sell
3,066
-4,851
-61% -$9.16K ﹤0.01% 1908
2025
Q2 		$9.97K Sell
7,917
-5,614
-41% -$5.52K ﹤0.01% 1817
2025
Q1 		$12.4K Buy
13,531
+10,769
+390% +$14K ﹤0.01% 1779
2024
Q4 		$4.39K Buy
+2,762
New +$5.55K ﹤0.01% 1907

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Federated Hermes's CRBU Position: Q2 2026 in Review

Federated Hermes held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 2,722 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Federated Hermes first reported a position in CRBU in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.4K in Q1 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Federated Hermes held 2,722 shares of Caribou Biosciences worth $4.79K as of Q2 2026.
  • Federated Hermes left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1925 holding.
  • Federated Hermes first reported a position in Caribou Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Federated Hermes's Caribou Biosciences position peaked at $12.4K in Q1 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.